Life Spine has announced that the US Food and Drug Administration (FDA) has provided 510(k) market clearance for the ProLift lateral expandable spacer system.
“The ProLift lateral expandable spacer system is a significant addition to Life Spine’s rapidly growing expandable portfolio. The device will be available in a multitude of footprints and lordotic options, allows for post-packing in situ, has anatomically convex endplates and has Life Spine’s proprietary OSSEO-LOC surface technology,” said Rich Mueller, COO of Life Spine.
The system features minimal insertion height and controlled, in situ expansion which are critical components in a MIS Expandable Lateral Interbody Fusion. The PROLIFT Lateral is complemented by Life Spine’s full lateral portfolio which consists of the CENTRIC Retractor, Lateral Disc Prep, OSTEO-LINE Graft Delivery Device, Neuromonitoring Instruments, LONGBOW Expandable Spacer System and the SENTRY Lateral Plating Systems.